337 related articles for article (PubMed ID: 24024177)
1. Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy.
Ganesh Yerra V; Negi G; Sharma SS; Kumar A
Redox Biol; 2013 Aug; 1(1):394-7. PubMed ID: 24024177
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of moxibustion simultaneously targeting Nrf2 and NF-κB in diabetic peripheral neuropathy.
Li J; Hu X; Liang F; Liu J; Zhou H; Liu J; Wang H; Tang H
Appl Biochem Biotechnol; 2019 Dec; 189(4):1167-1182. PubMed ID: 31209719
[TBL] [Abstract][Full Text] [Related]
3. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades.
Negi G; Kumar A; Sharma SS
J Pineal Res; 2011 Mar; 50(2):124-31. PubMed ID: 21062351
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 and NF-κB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes.
Negi G; Kumar A; Sharma SS
Curr Neurovasc Res; 2011 Nov; 8(4):294-304. PubMed ID: 22023613
[TBL] [Abstract][Full Text] [Related]
5. Fisetin Imparts Neuroprotection in Experimental Diabetic Neuropathy by Modulating Nrf2 and NF-κB Pathways.
Sandireddy R; Yerra VG; Komirishetti P; Areti A; Kumar A
Cell Mol Neurobiol; 2016 Aug; 36(6):883-892. PubMed ID: 26399251
[TBL] [Abstract][Full Text] [Related]
6. Nrf2: a potential therapeutic target for diabetic neuropathy.
Kumar A; Mittal R
Inflammopharmacology; 2017 Aug; 25(4):393-402. PubMed ID: 28353124
[TBL] [Abstract][Full Text] [Related]
7. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy.
Bachewal P; Gundu C; Yerra VG; Kalvala AK; Areti A; Kumar A
Biofactors; 2018 Mar; 44(2):109-122. PubMed ID: 29193444
[TBL] [Abstract][Full Text] [Related]
8. Taurine ameliorates neuropathy via regulating NF-κB and Nrf2/HO-1 signaling cascades in diabetic rats.
Agca CA; Tuzcu M; Hayirli A; Sahin K
Food Chem Toxicol; 2014 Sep; 71():116-21. PubMed ID: 24907624
[TBL] [Abstract][Full Text] [Related]
9. Cross Talk in HEK293 Cells Between Nrf2, HIF, and NF-κB Activities upon Challenges with Redox Therapeutics Characterized with Single-Cell Resolution.
Johansson K; Cebula M; Rengby O; Dreij K; Carlström KE; Sigmundsson K; Piehl F; Arnér ES
Antioxid Redox Signal; 2017 Feb; 26(6):229-246. PubMed ID: 26415122
[TBL] [Abstract][Full Text] [Related]
10. Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic neuropathy.
Kumar A; Negi G; Sharma SS
Biochimie; 2012 May; 94(5):1158-65. PubMed ID: 22342224
[TBL] [Abstract][Full Text] [Related]
11. Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway.
Mittal R; Kumar A; Singh DP; Bishnoi M; Nag TC
Inflammopharmacology; 2018 Jun; 26(3):755-768. PubMed ID: 29094308
[TBL] [Abstract][Full Text] [Related]
12. Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.
Wardyn JD; Ponsford AH; Sanderson CM
Biochem Soc Trans; 2015 Aug; 43(4):621-6. PubMed ID: 26551702
[TBL] [Abstract][Full Text] [Related]
13. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy.
Patel S; Khan H; Majumdar A
Metab Brain Dis; 2022 Oct; 37(7):2181-2195. PubMed ID: 35616799
[TBL] [Abstract][Full Text] [Related]
15. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of Aureusidin in LPS-stimulated RAW264.7 macrophages via suppressing NF-κB and activating ROS- and MAPKs-dependent Nrf2/HO-1 signaling pathways.
Ren J; Su D; Li L; Cai H; Zhang M; Zhai J; Li M; Wu X; Hu K
Toxicol Appl Pharmacol; 2020 Jan; 387():114846. PubMed ID: 31790703
[TBL] [Abstract][Full Text] [Related]
17. Pogostone attenuates TNF-α-induced injury in A549 cells via inhibiting NF-κB and activating Nrf2 pathways.
Yang HM; Zhuo JY; Sun CY; Nie J; Yuan J; Liu YL; Lin RF; Lai XP; Su ZR; Li YC
Int Immunopharmacol; 2018 Sep; 62():15-22. PubMed ID: 29966943
[TBL] [Abstract][Full Text] [Related]
18. Epicatechin induces NF-kappaB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells.
Granado-Serrano AB; Martín MA; Haegeman G; Goya L; Bravo L; Ramos S
Br J Nutr; 2010 Jan; 103(2):168-79. PubMed ID: 20030899
[TBL] [Abstract][Full Text] [Related]
19. JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence.
Kumar A; Negi G; Sharma SS
Diabetes Obes Metab; 2011 Aug; 13(8):750-8. PubMed ID: 21447040
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of resveratrol attenuates the severity of diabetic neuropathy by activating the Nrf2 pathway.
Zhang W; Yu H; Lin Q; Liu X; Cheng Y; Deng B
Aging (Albany NY); 2021 Mar; 13(7):10659-10671. PubMed ID: 33770763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
